Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
32.80    0.10 (0.31%)
Bid:
32.60
Ask:
33.00
Spread: 0.40 (1.227%)
Market Cap: £24.08m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

12 Oct 2018 07:00

RNS Number : 8202D
Carclo plc
12 October 2018
 

Carclo plc ("the Group")

Trading update - full year expectations unchanged

Trading in the first half was below the Board's expectations due to underperformance at Technical Plastics.

In Technical Plastics, three new medical programmes were delayed by customers in the period but all entered production successfully towards the end of the first half of the year and this, together with planned new tooling programmes, support the expected stronger second half performance. The implementation of our operational improvement programme has delivered a number of price increases, efficiency opportunities and cost savings across the division, the benefit of which will positively impact margins in the second half of the year and beyond.

In the LED Division, Wipac has continued to be successful in winning new programmes, including nomination for two mid-volume electric vehicles, leading to a healthy level of design and development contract profits. Production demand has been solid. All of the current year's planned new vehicle production programmes launched in the first half and this resulted in higher than anticipated manufacturing costs being incurred during launch. Associated margins are expected to improve in the second half as production accelerates and initial start-up inefficiencies are eliminated.

The smaller Aerospace Division performed slightly ahead of expectations as a result of higher margins and tight control over costs.

The Board's expectations for the year ending 31 March 2019 remain unchanged, with results weighted towards the second half of the year, as expected. This reflects the full effect of the new programmes, expected customer timings on projects and the anticipated improvement in margins at Wipac in addition to cost saving initiatives, ramp up in production volumes and expected higher design and tooling profits in Technical Plastics.

The Group will announce its interim results for the period ended 30 September 2018 on 13 November 2018.

For further information please contact:

Carclo plc

Chris Malley, Chief Executive 01924 268040

Sarah Matthews-DeMers, Group Finance Director

 

Peel Hunt LLP (Corporate broker)

Justin Jones 0207 418 8900

Sam Cann

 

Weber Shandwick Financial (Financial PR)

Nick Oborne 020 7067 0700

 

Notes to editors

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there remain significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of Group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of Group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSAIELLLIT
Date   Source Headline
13th Jun 20057:01 amRNSFinal Results
26th May 20057:02 amRNSDisposal
20th May 20058:30 amRNSNegotiations re Disposal
17th May 200511:05 amRNSNotice of Results
1st Apr 20057:00 amRNSPre-close Trading Update
17th Feb 200511:30 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.